Skip to content
Brand AI

BOTOX

Recent events

Recent events tied to this brand in public sources.

Back to profile2 entries

  1. 2021

    FDA approves Botox label expansion for adult upper limb spasticity

    The FDA approved a Botox label expansion to include eight additional muscles and ultrasound use for treatment of upper limb spasticity in adults.

    Source

  2. 2019

    FDA approves BOTOX for pediatric lower limb spasticity

    The FDA approved Allergan’s supplemental application to expand BOTOX (onabotulinumtoxinA) treatment to pediatric patients aged 2 to 17 with lower limb spasticity, excluding spasticity caused by cerebral palsy.

    Source